Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIO-US B07: Neoadjuvant Trastuzumab and Lapatinib in HER2+ Breast Cancer
NCT00769470Phase 2Completed
- Sponsor
- TRIO
- Start
- Apr 2009
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by TRIO. Started Apr 2009; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00769470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00769470.